Evidence map›Paper›PMID 35428787›Full record

ArticleScientific reports2022

CRISPRi for specific inhibition of miRNA clusters and miRNAs with high sequence homology.

Monika Drobna-Śledzińska, Natalia Maćkowska-Maślak, Roman Jaksik, Paulina Dąbek, Michał Witt, Małgorzata Dawidowska

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. CRISPR-Activation: Boosting Expression of Plant MIRs.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Monika Drobna-ŚledzińskaInstitute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznań, Poland. monika.drobna@igcz.poznan.pl.ORCID 0000-0003-1671-9071
Natalia Maćkowska-MaślakInstitute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznań, Poland.ORCID 0000-0002-0296-4597
Roman JaksikSilesian University of Technology, Akademicka 16, 44-100, Gliwice, Poland.ORCID 0000-0003-1866-6380
Paulina DąbekInstitute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznań, Poland.
Michał WittInstitute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznań, Poland.ORCID 0000-0003-1729-4159
Małgorzata DawidowskaInstitute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznań, Poland. malgorzata.dawidowska@igcz.poznan.pl.ORCID 0000-0003-3486-6577
Institute of Human Genetics · PLSilesian University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miRNAs form a class of noncoding RNAs, involved in post-transcriptional regulation of gene expression, broadly studied for their involvement in physiological and pathological context. Inhibition of mature miRNA transcripts, commonly used in miRNA loss-of-function experiments, may not be specific in case of miRNAs with high sequence homology, e.g. miRNAs from the same seed family. Phenotypic effects of miRNA repression might be biased by the repression of highly similar miRNAs. Another challenge is simultaneous inhibition of multiple miRNAs encoded within policistronic clusters, potentially co-regulating common biological processes. To elucidate roles of miRNA clusters and miRNAs with high sequence homology, it is of key importance to selectively repress only the miRNAs of interest. Targeting miRNAs on genomic level with CRISPR/dCas9-based methods is an attractive alternative to blocking mature miRNAs. Yet, so far no clear guidelines on the design of CRISPR inhibition (CRISPRi) experiments, specifically for miRNA repression, have been proposed. To address this need, here we propose a strategy for effective inhibition of miRNAs and miRNA clusters using CRISPRi. We provide clues on how to approach the challenges in using CRISPR/dCas in miRNA studies, which include prediction of miRNA transcription start sites (TSSs) and the design of single guide RNAs (sgRNAs). The strategy implements three TSS prediction online tools, dedicated specifically for miRNAs: miRStart, FANTOM 5 miRNA atlas, DIANA-miRGen, and CRISPOR tool for sgRNAs design; it includes testing and selection of optimal sgRNAs. We demonstrate that compared to siRNA/shRNA-based miRNA silencing, CRISPRi improves the repression specificity for miRNAs with highly similar sequence and contribute to higher uniformity of the effects of silencing the whole miRNA clusters. This strategy may be adapted for CRISPR-mediated activation (CRISPRa) of miRNA expression.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsMicroRNAsRNA, Guide, CRISPR-Cas SystemsSequence HomologyTranscription Initiation SiteMicroRNAsRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID35428787
PMCPMC9012752
OpenAlexW4223914174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.